Photobiomodulation for the Management of Temporomandibular Disorder Pain — PBM  

Pain Related to TMD Clinical Trial

Official title: Photobiomodulation for the Management of Temporomandibular Disorder Pain

Status Terminated

Clinical Trial Summary

Photobiomodulation (PBM), is FDA-approved for temporary relief of muscle and joint pain, but there is no indication for TMD. Our goal in this study is to conduct a clinical trial of multimodal PBM for TMD pain. Also, we propose to determine if PBM-induced changes in inflammation contribute to PBM's analgesic effects. This study will be a double-blind, sham-controlled, randomized trial testing the efficacy of PBM for pain related to TMD.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Pain Related to TMD
• Temporomandibular Joint Disorders
• Temporomandibular Joint Dysfunction Syndrome

• NCT number: NCT04415281
• Study type: Interventional
• Source: University of Florida
• Status: Terminated
• Phase: N/A
• Start date: April 28, 2021
• Completion date: December 16, 2022